November 2024 Tender Notification

29 November 2024

Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2023/24 Invitation to Tender dated 31 October 2023.

Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceutical under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:

For new listings, by 4pm on the 12th of December 2024 or the 5^th of the month prior to listing, whichever is earlier
For price changes, by 4pm on the 12^th of the month prior to the date of subsidy change

Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to Pharmac by the 5^th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode.

29 November 2024 Tender Notification [PDF 186 KB]

2023/24 Tender – Principal Supply Status applies until 30 June 2027

Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule

The decisions were as follows:

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Chemical name	Presentation; Pack size and type	Current pack price (and subsidy)	New pack price	Principal Supply brand (Supplier)	Date of subsidy change	Principal Supply date
Econazole nitrate	crm 1%; 20 g tube pack OP	$8.09 ($1.00)	$8.04	Pevaryl (Inova)	1 January 2025	1 June 2025

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name	Presentation; Pack size and type	Current pack price	New pack price	Principal Supply brand (Supplier)	Listing date	Principal Supply date	Brand (Supplier) affected by delisting
Acetazolamide	tab 250 mg; 100 tablet bottle pack	$17.03	$13.96	Medsurge (Medsurge)	1 April 2025	1 September 2025	Diamox (Arrotex)

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.

3. Tenders awarded to pharmaceuticals where no brand is listed.

Chemical name	Presentation; Pack size and type	New pack price	Principal Supply brand (Supplier)	DV Limit	Date of subsidy change	Principal Supply date
Econazole nitrate	crm 1%; 20 g tube pack	$8.04	Pevaryl (Inova)	5%	1 January 2025	1 June 2025

4. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name	Presentation; Pack size and type	Current pack price	New pack price	Principal Supply brand (Supplier)	DV Limit	Listing date	Principal Supply date	Brand (Supplier) affected by delisting (Pharmacode)
Acetazolamide	tab 250 mg; 100 tablet bottle pack	$17.03	$13.96	Medsurge (Medsurge)	5%	1 April 2025	1 September 2025	Diamox (Arrotex)

For products included in the 2022/23 and 2023/24 Invitation to Tender where no announcement has yet been made, a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.